uniQure N.V. · Healthcare · Pharmaceutical Products
As of 2026-06-26, uniQure N.V. (QURE) has a 3-month relative strength percentile of 98 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 88. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.9%, relative volume 1.06×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 98, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
QURE appears in 1 ETF as of Mar 2026: VXF at 0.01% weight, $11M notional.
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VXFVanguard Extended Market ETF | 0.01% | $11M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | QURE Jan avg: -10.02% median: -8.57% win: 0% σ: 5.81% n: 4 2022-04-12 → 2026-05-29 | QURE Feb avg: -11.40% median: -8.91% win: 25% σ: 15.68% n: 4 2022-04-12 → 2026-05-29 | QURE Mar avg: -7.07% median: -6.74% win: 25% σ: 10.07% n: 4 2022-04-12 → 2026-05-29 | QURE Apr avg: 4.68% median: -3.62% win: 40% σ: 25.11% n: 5 2022-04-12 → 2026-05-29 | QURE May avg: 9.76% median: -0.62% win: 40% σ: 19.64% n: 5 2022-04-12 → 2026-05-29 | QURE Jun avg: -5.99% median: -6.58% win: 25% σ: 28.85% n: 4 2022-04-12 → 2026-05-29 (current) | QURE Jul avg: 24.33% median: 17.93% win: 50% σ: 36.77% n: 4 2022-04-12 → 2026-05-29 | QURE Aug avg: -11.31% median: -19.46% win: 25% σ: 19.39% n: 4 2022-04-12 → 2026-05-29 | QURE Sep avg: 53.69% median: -9.86% win: 25% σ: 136.06% n: 4 2022-04-12 → 2026-05-29 | QURE Oct avg: 4.05% median: 7.61% win: 50% σ: 14.98% n: 4 2022-04-12 → 2026-05-29 | QURE Nov avg: 1.52% median: 11.66% win: 75% σ: 43.46% n: 4 2022-04-12 → 2026-05-29 | QURE Dec avg: 42.08% median: -6.58% win: 25% σ: 102.69% n: 4 2022-04-12 → 2026-05-29 |